Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nanosonics Limited ( (AU:NAN) ) has provided an announcement.
UBS Group AG and its related bodies corporate have become substantial holders in Nanosonics Limited, with a voting power of 5.22% as of June 30, 2025. This development indicates a significant investment interest from UBS, potentially impacting Nanosonics’ market positioning and signaling confidence in the company’s future prospects.
The most recent analyst rating on (AU:NAN) stock is a Hold with a A$3.75 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, focusing on infection prevention solutions. The company is known for its innovative products that aim to improve patient safety and reduce the risk of infection in healthcare settings.
Average Trading Volume: 977,561
Technical Sentiment Signal: Buy
Current Market Cap: A$1.23B
See more data about NAN stock on TipRanks’ Stock Analysis page.